Astra's Trastuzumab Deruxtecan Achieves Tumour Response Rate Of 60.9% Read More
UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset Read More
DeepMatter Shares Surge On AstraZeneca DigitalGlassware Collaboration Read More
Positive Results From AstraZeneca Trial Of Calquence Drug In Leukaemia Read More
AstraZeneca, Merck Get Marketing Authorization In China For Lynparza Read More
AstraZeneca Divests North American Seroquel and Seroquel XR Rights Read More
TOP NEWS: AstraZeneca's Imfinzi Gains Priority Review From US FDA Read More
LONDON MARKET PRE-OPEN: Ocado Signs Deal In Japan; Reach Decline Slows Read More
UK BROKER RATINGS SUMMARY: Morgan Stanley Downgrades Rolls-Royce Read More
LONDON MARKET OPEN: Promising Start Amid Blue-Chip Exec Changes Read More
US Approves AstraZeneca's Calquence In Chronic Lymphocytic Leukaemia Read More
European Commission Gives Approval To AstraZeneca Diabetes Drug Read More
TOP NEWS: Astra, Merck Gets US Priority Review For Rare Genetic Drug Read More
Astra's Anifrolumab Shows Advantage Across Various Efficacy Endpoints Read More
UK WINNERS & LOSERS SUMMARY: Greggs Surges 17% After Raising Guidance Read More
LONDON MARKET OPEN: Stocks Lower But Sirius Minerals And Greggs Gain Read More
TOP NEWS: AstraZeneca Reports Positive Test Results For Anaemia Drug Read More
AstraZeneca Drug Roxadustat Increases Haemoglobin Levels In Two Trials Read More
UPDATE: AstraZeneca To Present Encouraging Data From Calquence Trial Read More
AstraZeneca Steps Up China Presence With USD1 Billion Fund, R&D Centre Read More
